1. Analyst View

2. Global Contract Manufacturing Market
2.1 Rising Trend of Outsourcing
2.2 Market Analysis
2.2.1 Market Size
2.2.1.1 Chemical Synthesis
2.2.1.2 Formulations & Packaging

3. India - Most Potential Contract Manufacturing Destination
3.1 Pharma Outsourcing Market
3.1.1 Contract Manufacturing Market
3.1.1.1 Chemical Synthesis
3.1.1.2 Formulation & Packaging
3.2 Manufacturing Analysis
3.2.1 Bulk Drugs
3.2.2 Formulations
3.2.3 Drug Packaging
3.2.4 Biopharmaceuticals
3.3 Cost Analysis
3.3.1 Employment Cost
3.3.2 Office Rental Cost
3.3.3 Industrial Land Rental Cost
3.3.4 Construction Cost
3.3.5 Cost of Utilities
3.3.6 Freight Cost
3.4 Analysis of Human Resources
3.4.1 Pharma Personnel
3.4.2 Pharma-related Degrees
3.5 Infrastructure Analysis
3.5.1 Manufacturing
3.5.2 Logistics
3.5.3 ICT
3.5.4 Energy Capacity & Production

4. Industry Analysis
4.1 Market Drivers
4.1.1 Increasing Prevalence of Generics
4.1.2 Cost Advantage
4.1.3 Well-developed Infrastructure
4.1.4 Improved IPR Laws
4.1.5 Emerging Pharmaceutical Market
4.1.6 Huge Pool of Human Resources
4.2 Opportunities
4.2.1 Supplementary Services in Pharma Outsourcing
4.2.2 Third Party Logistics Market
4.2.3 Pharma Machinery Market
4.2.4 Real Estate Market
4.3 Challenges & Threats
4.3.1 Counterfeit Drugs
4.3.2 High Wage Inflation & Attrition
4.3.3 Currency Appreciation
4.3.4 Threats from China

5. Key Players
5.1 Divis Laboratories Limited
5.2 Dr. Reddy's Laboratories Limited
5.3 Nicholas Piramal India Limited
5.4 Jubilant Organosys Healthcare Limited
5.5 Shasun Chemicals and Drugs Limited
5.6 Dishman Pharmaceuticals & Chemicals Limited

List of Figures:

Figure 2-1: Global - Contract Manufacturing Market (in Billon US$), 2006 & 2007E
Figure 2-2: Global - Forecast for Contract Manufacturing Market (in Billon US$), 2008-2012
Figure 2-3: Global - Contract Manufacturing Market by Type of Manufacturing (%), 2006
Figure 2-4: Global - Chemical Synthesis Market by In-house & Outsourced Manufacturing (%)
Figure 2-5: Global - Contract Chemical Synthesis Market (in Billon US$), 2006, 2007E, 2010F & 2012F
Figure 2-6: Global - Contract Formulations & Packaging Market (in Billlon US$), 2006, 2007E, 2010F & 2012F
Figure 2-7: Global - Formulations Market by In-house & Outsourced Manufacturing (%)
Figure 2-8: Global - Contract Dose Manufacturing Market by Type of Drug (%), 2006
Figure 3-1: India - Pharma Outsourcing Market (in Million US$), 2004-2007E
Figure 3-2: India - Pharma Outsourcing Market by Segment (%), 2006
Figure 3-3: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2012
Figure 3-4: India - Contract Manufacturing Market (in Millon US$), 2004-2007E
Figure 3-5: India - Forecast for Contract Manufacturing Market (in Millon US$), 2008-2012
Figure 3-6: India - Contract Manufacturing Market by Type of Manufacturing (%), 2006
Figure 3-7: India - Contract Chemical Synthesis Market (in Millon US$), 2006, 2007E & 2012F
Figure 3-8: India - Contract Formulations & Packaging Market (in Million US$), 2006, 2007E & 2012F
Figure 3-9: India - Bulk Drug Production* (in Billion INR), 2001-02 to 2006-07E
Figure 3-10: India - Formulations Production* (in Billion INR), 2001-02 to 2006-07E
Figure 3-11: India - Drug Packaging Market (in Billion INR), 2006-07 & 2011-12F
Figure 3-12: Global - Contract Biopharmaceutical Manufacturing Market (in Billion US$), 2004, 2006 & 2007E
Figure 3-13: Global - Forecast for Contract Biopharmaceutical Manufacturing Market (in Billion US$), 2008-2012
Figure 3-14: Global - Biopharmaceutical Manufacturing Market by Segment (%), 2007E
Figure 3-15: India - Biopharmaceutical Market (in Billion INR), 2002-03 to 2006-07 & 2011-12F
Figure 3-16: India - Relative Annual Cost of Bioscale-up Manufacturing w.r.t. Other Countries
Figure 3-17: India - Relative Annual Cost of Secondary Manufacturing w.r.t. Other Countries
Figure 3-18: India - Office Rental Cost w.r.t Other Countries (in US$/Sq. Metre), 2003
Figure 3-19: India - Industrial Land Rental Cost w.r.t. Other Countries (in US$/Sq. Metre), 2003
Figure 3-20: India - Construction Cost w.r.t Other Countries (in US$/Sq. Metre), 2003
Figure 3-21: India - Number of FDA Approved Plants w.r.t. Other Countries, 2006
Figure 3-22: India - Cost of Logistics as Percentage of GDP w.r.t. Other Countries, 2006
Figure 3-23: India - Average Distance Covered by Truck w.r.t. Other Countries (in Km/day), 2006
Figure 3-24: India - Average Turnaround Time at Ports w.r.t. Other Countries (in Hours), 2006
Figure 4-1: Global - Generic Market (in Billion US$), 2001-2007E & 2010F
Figure 4-2: India - Domestic Pharmaceutical Market* (in Billion INR), 2002-03 to 2006-07 & 2011-12F
Figure 4-3: Global - Supplementary Services in Pharma Outsourcing Market (in Billion US$), 2006 & 2010F
Figure 4-4: India - Supplementary Services in Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007E
Figure 4-5: India - Forecast for Supplementary Services in Pharma Outsourcing Market (in Million US$), 2008-2010
Figure 4-6: India - Logistics Market (in Billion US$), 2006 & 2010F
Figure 4-7: India - Outsourced Logistics Market (in Billion US$), 2006 & 2010F
Figure 4-8: India - Pharma Machinery Market (in Billion INR), 2004, 2007E & 2010F
Figure 4-9: India - Real Estate Market (in Billion US$), 2006 & 2015F
Figure 4-10: India - Attrition in Pharma Market w.r.t. Global Level (%), 2005
Figure 4-11: India - Currency Exchange Rate* (From US$ to INR), 2001-2008

List of Tables:

Table 3-1: India - Bioscale-up Manufacturing Cost Model w.r.t. Other Countries (in US$)
Table 3-2: India - Secondary Manufacturing Cost Model w.r.t. Other Countries (in US$)
Table 3-3: India - Annual Cost of Pharma-related Labor w.r.t. Other Countries (in US$), 2004
Table 3-4: India - Cost of Utilities (Electricity, Gas, Water, Phone & Internet) w.r.t. Other Countries (in US$), 2004
Table 3-5: Cost of Freight to & from India w.r.t. Other Countries (in US$), 2004
Table 3-6: India - Number of Pharmaceutical Personnels w.r.t. Other Countries, 2003E
Table 3-7: India - Number of Pharma-related Graduate Degrees w.r.t. Other Countries, 2002
Table 3-8: India - Number of Pharma-related Masters Degrees w.r.t. Other Countries, 2002
Table 3-9: India - Number of Pharma-related Doctorate & Post Doctorate Degrees w.r.t Other Countries, 2002
Table 3-10: India - ICT Infrastructure w.r.t. Other Countries, 2007E
Table 3-11: India - Electricity Capacity & Production w.r.t. Other Countries, 2006
Table 4-1: India - Estimated Share of Counterfeit Drugs in Pharma Market (%)
Table 5-1: Divis Laboratories Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
Table 5-2: Dr. Reddy's Laboratories Limited - Key Financials (in Million US$), Mar 2005 to Mar 2007
Table 5-3: Nicholas Piramal India Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
Table 5-4: Jubilant Organosys Healthcare Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
Table 5-5: Shasun Chemicals and Drugs Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007
Table 5-6: Dishman Pharmaceuticals & Chemicals Limited - Key Financials (in Million INR), Mar 2006 & Mar 2007